NBW Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.1M | Buy |
15,939
+293
| +2% | +$130K | 1.53% | 22 |
|
|
2025
Q1 | $7.59M | Sell |
15,646
-4,592
| -23% | -$2.23M | 1.68% | 15 |
|
|
2024
Q4 | $8.15M | Sell |
20,238
-351
| -2% | -$141K | 1.51% | 25 |
|
|
2024
Q3 | $9.58M | Buy |
20,589
+240
| +1% | +$112K | 1.81% | 17 |
|
|
2024
Q2 | $9.54M | Sell |
20,349
-94
| -0.5% | -$44.1K | 1.88% | 12 |
|
|
2024
Q1 | $8.55M | Buy |
20,443
+1,011
| +5% | +$423K | 1.75% | 15 |
|
|
2023
Q4 | $7.91M | Buy |
19,432
+8,145
| +72% | +$3.31M | 1.73% | 17 |
|
|
2023
Q3 | $3.92M | Buy |
11,287
+9
| +0.1% | +$3.13K | 0.96% | 51 |
|
|
2023
Q2 | $3.97M | Buy |
11,278
+47
| +0.4% | +$16.5K | 0.93% | 52 |
|
|
2023
Q1 | $3.54M | Buy |
11,231
+309
| +3% | +$97.4K | 0.86% | 57 |
|
|
2022
Q4 | $3.15M | Buy |
+10,922
| New | +$3.15M | 0.81% | 59 |
|